Literature DB >> 11487038

Cost-effective diagnosis of deep vein thrombosis and pulmonary embolism.

A Perrier1, H Bounameaux.   

Abstract

Suspected acute venous thromboembolism is a frequent and challenging clinical problem. Phlebography and pulmonary angiography are costly and invasive and, hence, ill-suited for diagnosing a disease present in only 20% of patients in whom it is suspected. Novel noninvasive instruments, such as plasma D-dimer measurement, lower limb compression ultrasonography and helical CT scan are important breakthroughs in the management of patients with suspected venous thromboembolism. However, none of these instruments is ideal, and they must be combined in rational and cost-effective diagnostic algorithms including clinical assessment, which is increasingly standardized. Such strategies must be validated in management studies, in which patients without venous thromboembolism are not treated and followed up during 3 months. Suspected massive pulmonary embolism is a distinct clinical situation requiring a specific diagnostic approach, in which echocardiography plays a major role. This paper reviews the performance of clinical evaluation and diagnostic tests for venous thromboembolism, and recently validated diagnostic schemes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487038

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Multiple abdominal veins thrombosis secondary to protein s deficiency - a case report.

Authors:  Venkata Umakant Kodali; Seshulakshmi Borra; Surendra Babu Mandarapu; Mallikarjuna Rao Sanda; Srinivasa Rao Bolla
Journal:  J Clin Diagn Res       Date:  2014-06-20

Review 2.  Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future.

Authors:  Giuseppe Lippi; Gianfranco Cervellin; Massimo Franchini; Emmanuel J Favaloro
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

Review 3.  Diagnosing pulmonary embolism.

Authors:  M Riedel
Journal:  Postgrad Med J       Date:  2004-06       Impact factor: 2.401

4.  [Therapeutic approaches to acute pulmonary embolism].

Authors:  A Reissig; C Kroegel
Journal:  Internist (Berl)       Date:  2004-05       Impact factor: 0.743

5.  The role of d-dimer as first marker of thrombophilia in women affected by sterility: implications in pathophysiology and diagnosis of thrombophilia induced sterility.

Authors:  Pierpaolo Di Micco; Maristella D'Uva; Ida Strina; Antonio Mollo; Valeria Amato; Alferio Niglio; Giuseppe De Placido
Journal:  J Transl Med       Date:  2004-11-09       Impact factor: 5.531

6.  Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer.

Authors:  K Uno; S Homma; T Satoh; K Nakanishi; D Abe; K Matsumoto; A Oki; H Tsunoda; I Yamaguchi; T Nagasawa; H Yoshikawa; K Aonuma
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

7.  Deep Vein Thrombosis in Patients with Pulmonary Embolism: Prevalance, Clinical Significance and Outcome.

Authors:  Jun Sung Lee; Tong Moon; Tae Hoon Kim; Se Young Kim; Jun Young Choi; Kyung Bok Lee; Yu Jin Kwon; Suk Hee Song; Su Hyun Kim; Hae Ok Kim; Ho Kyeong Hwang; Min Ji Kim; Young Kyoung Lee
Journal:  Vasc Specialist Int       Date:  2016-12-31

8.  Risk Factors for Postoperative Venous Thromboembolic Events in Patients Undergoing Lumbar Spine Surgery.

Authors:  Alexander Nazareth; Anthony D'Oro; John C Liu; Kyle Schoell; Patrick Heindel; Andre Jakoi; Raymond Hah; Jeffrey C Wang; Zorica Buser
Journal:  Global Spine J       Date:  2018-08-29

9.  Antiphospholipid Syndrome-Related Pulmonary Embolism: Clinical Characteristics and Early Recognition.

Authors:  Maojing Shi; Weibo Gao; Yuebo Jin; Jihong Zhu; Yuansheng Liu; Tianbing Wang; Chun Li
Journal:  Front Cardiovasc Med       Date:  2022-07-11

10.  Prediction of prognosis and outcome of patients with pulmonary embolism in the emergency department using early warning scores and qSOFA score.

Authors:  Sadiye Yolcu; Adem Kaya; Nurettin Yilmaz
Journal:  J Int Med Res       Date:  2022-10       Impact factor: 1.573

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.